PHI with Micronodular cirrhosis of liver
How does this condition affect your private health insurance?
Micronodular liver cirrhosis, also known as Laennec's cirrhosis, is a severe, chronic liver disease characterized by diffuse fibrosis and the formation of small, uniform regenerative nodules, typically less than 3 mm in diameter. This architecture disrupts normal liver function, leading to impaired detoxification, protein synthesis, and bile flow. Common causes include chronic alcohol abuse, chronic viral hepatitis (B and C), non-alcoholic steatohepatitis (NASH), and autoimmune diseases. Symptoms often manifest late and include fatigue, jaundice, ascites, portal hypertension, and encephalopathy. It's a progressive and irreversible condition.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms develop insidiously over months to years; acute decompensation episodes can last days to weeks.
Duration of Illness (Lifetime)
Chronic and progressive, lifelong once established.
Cost of Treatment (Initial)
High (e.g., thousands to tens of thousands of USD, depending on severity and need for hospitalization).
Cost of Treatment (Lifetime)
Very high (hundreds of thousands to millions of USD, especially with potential liver transplant).
Mortality Rate
High, particularly in advanced or decompensated stages (e.g., 5-year survival rates can be below 50% for decompensated cirrhosis).
Risk of Secondary Damages
Very high (near 100% for complications like portal hypertension, ascites, or encephalopathy in advanced stages; also hepatocellular carcinoma).
Probability of Full Recovery
Extremely low; established cirrhosis is irreversible and generally does not allow for complete recovery without a liver transplant.
Underlying Disease Risk
High for chronic liver diseases such as chronic viral hepatitis (B/C), chronic alcohol abuse, non-alcoholic steatohepatitis (NASH), or autoimmune liver diseases.